Citation 1: Paik SH, Chakicherla A, Hansen JN, et al. Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168. J Biol Chem. 1998;273(36):23134-42. Published 1998 Sep 4. doi:10.1074/jbc.273.36.23134
Citation 2: Kunst F, Ogasawara N, Moszer I, et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997;390(6657):249-56. Published 1997 Nov 20. doi:10.1038/36786
Citation 3: Stepper J, Shastri S, Loo TS, et al. Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins. FEBS Lett. 2011;585(4):645-50. Published 2011 Feb 18. doi:10.1016/j.febslet.2011.01.023
Citation 4: Oman TJ, Boettcher JM, Wang H, et al. Sublancin is not a lantibiotic but an S-linked glycopeptide. Nat Chem Biol. 2011;7(2):78-80. Published 2011 Feb. doi:10.1038/nchembio.509
Citation 5: Dorenbos R, Stein T, Kabel J, et al. Thiol-disulfide oxidoreductases are essential for the production of the lantibiotic sublancin 168. J Biol Chem. 2002;277(19):16682-8. Published 2002 May 10. doi:10.1074/jbc.M201158200
Citation 6: Dubois JY, Kouwen TR, Schurich AK, et al. Immunity to the bacteriocin sublancin 168 Is determined by the SunI (YolF) protein of Bacillus subtilis. Antimicrob Agents Chemother. 2009;53(2):651-61. Published 2009 Feb. doi:10.1128/AAC.01189-08